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ABSTRACT
this article aims to examine the potential health effects of the trans-
atlantic trade and investment partnership (ttiP). our review in-
dicates that, although proponents of the ttiP claim that the treaty 
will produce benefits to health-enhancing determinants such as 
economic growth and employment, evidence shows that previous 
trade liberalization policies are associated with increasing economic 
inequities.
By reducing technical Barriers to trade (tBt) and by promoting 
increased cooperation between Us and eU governmental agencies 
in the pharmaceutical sector, the ttiP could result in improved re-
search cooperation and reduced duplication of processes. However, 
the ttiP chapter on intellectual Property (iP) and trade-related 
Aspects of intellectual Property rights (triPs) that expand and ex-
tend patent monopolies, and delay the availability of generic drugs, 
are likely to cause underutilization of needed medications among 
vulnerable populations.
the ttiP’s investor to state dispute settlement (isds) arbitration 
system, a mechanism that allows transnational companies (tncs) 
to sue governments when a policy or law reduces the value of their 
investment, is likely to generate a negative impact on regulations 
aimed at increasing access to healthcare, and reducing tobacco, alco-
hol consumption, and diet-related diseases.
the sanitary and Phytosanitary standards (sPs) of the ttiP is ex-
pected to weaken regulations in the food and agricultural sectors 
especially in the eU, with potentially negative effects on food safety 
and foodborne diseases.
Finally, the isds is likely to infringe the ability of governments to 
tackle environmental problems such as climate change deemed to be 
the most important global health threat of the century.
our review concludes by discussing policy implications and the ef-
fect of the ttiP on democracy, national sovereignty and the balance 
of power between large tncs and governments. it also discusses the 
adoption of an “evidence-based precautionary principle approach” 
in dealing with the health impact of Free trade Agreements (FtAs) 
as well as the harmonization of regulations, norms, and standards 
toward stronger health and environmental protection.
Keywords: trade and health, health policy, European Union, United 
States
RIASSUNTO
scopo di questo articolo è esaminare i potenziali effetti sulla salu-
te del Partenariato transatlantico sul commercio e gli investimenti 
(Transatlantic Trade and Investment Partnership, ttiP). la presente 
analisi dimostra come, nonostante i promotori del ttiP sostenga-
no che il trattato produrrà effetti vantaggiosi su fattori in grado di 
migliorare la salute, quali la crescita economica e l’occupazione, l’e-
videnza storica documenti che le politiche di liberalizzazione com-
merciale tendono a incrementare le disuguaglianze economiche. 
riducendo gli ostacoli agli scambi commerciali (Technical Barriers to 
Trade, tBt) e promuovendo una maggiore cooperazione tra le agen-
zie governative statunitensi ed europee nel settore farmaceutico, il 
ttiP potrebbe portare a una migliore cooperazione nella ricerca far-
macologica e a una riduzione della duplicazione dei processi. tuttavia, 
il capitolo del ttiP sulla proprietà intellettuale (Intellectual Proper-
ty, iP) e sugli aspetti commerciali dei diritti di proprietà intellettuale 
(Trade-Related Aspects of Intellectual Property Rights, triPs) ha lo sco-
po di espandere ed estendere i monopoli di brevetti e, quindi, ritardare 
la disponibilità di farmaci generici in campo commerciale, causando 
un sottoutilizzo di farmaci necessari tra popolazioni vulnerabili. 
il sistema del ttiP di risoluzione delle controversie tra investitori 
e singoli stati (Investor to State Dispute Settlement, isds), che con-
sente alle corporazioni transnazionali (tnc) di citare in giudizio i 
governi ogniqualvolta un decreto, o una legge, sia in grado di ridurre 
il loro profitto, potrebbe avere un impatto negativo sullo sviluppo di 
riforme volte a incrementare l’accesso alle cure sanitarie e a ridurre il 
consumo di tabacco, alcol e alimenti insalubri. 
si prevede, inoltre, che le misure sanitarie e fitosanitarie (sPs) previ-
ste dal ttiP abbiano il potenziale effetto di indebolire le norme ri-
guardanti la sicurezza nel settore alimentare e agricolo, in particolare 
nell’Unione europea, con effetti potenzialmente negativi per quanto 
riguarda la prevalenza di malattie di origine alimentare. 
infine, la clausola dell’isds rischia di violare la libertà dei governi 
di promuovere accordi e leggi sulla protezione della salute rispetto 
a rischi ambientali come il cambiamento climatico, ritenuto la più 
grande minaccia del secolo per la salute globale. 
Questa rassegna si conclude con una discussione sulle implicazioni 
politiche e gli effetti del ttiP sulla democrazia, la sovranità nazio-
nale e l’equilibrio di potere tra le grandi multinazionali e i governi. 
si discute anche dell’adozione di un “approccio precauzionale ba-
sato sull’evidenza” nell’analizzare l’impatto degli accordi di libero 
scambio (Free Trade Agreements, FtA) sulla salute, nonché l’armo-
nizzazione di regolamenti, norme e standard verso una maggiore 
protezione della salute e dell’ambiente.
Parole chiave: commercio e salute, politica sanitaria, Unione europea, 
Stati uniti
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INTRODUCTION
since the G8 meeting in northern ireland in 2013, the 
european Union (eU) and the United states of America 
(UsA) have been negotiating the transatlantic trade and 
investment Partnership (ttiP).1 the ttiP, a companion 
trade agreement to the trans-Pacific Partnership (tPP) 
between eleven Pacific rim countries and the UsA, is part 
of an international trade agenda aimed at furthering poli-
cies of trade liberalization worldwide. some authors, how-
ever, consider the ttiP rather as a geopolitical project 
of the UsA in the context of its economic competition 
against china and the other members of the Brics (Bra-
zil, russia, india and south Africa) group of countries.2,3
the ttiP differs from previous Free trade Agreements 
(FtAs) in several respects. First, it is the largest ever FtA as 
it will affect countries that account for 50% of global Gross 
domestic Product (GdP). second, it is designed not only 
to reduce trade tariffs, but also to homogenize regulations, 
standards and investor protections between interested na-
tions. Proponents of the ttiP claim that this agreement can 
become a major stimulus for economic growth, trade and 
employment as well as a major vehicle for post 2008 reces-
sion recovery.4-6 opponents argue that the ttiP is essentially 
an investor protection treaty that will eventually enhance the 
power and wealth of large transnational companies (tncs), 
undermine democracy, weaken health-related regulations 
and produce a negative impact on population health.7-9
the aim of this article is to review the potential impact of 
the ttiP on public health. First, we assess how this poli-
cy can affect health-enhancing determinants such as eco-
nomic growth and employment. then, we examine the 
possible prospective effect of the ttiP on four categories 
of health outcomes: access to medicines and healthcare, 
tobacco and alcohol consumption, diet-related diseases 
and agriculture and environmental health. Finally, we ad-
dress the potential influence of the ttiP on democracy 
and national sovereignty and discuss policy implications 
for the protection and promotion of population health.
THE TTIP, ECONOMIC GROwTH AND EMPLOyMENT
since the creation of the General Agreement on tariffs 
and trade (GAtt) in 1947, economic growth has histori-
cally been the rationale and the justification behind trade 
liberalization – the reduction of trade barriers – and the 
development of new FtAs.10 trade liberalization policies 
that increase export opportunities to foreign markets, low-
er the cost of imported goods and attract foreign invest-
ment can, in theory, promote economic growth.11 income 
generated from trade policies may, in turn, lead to better 
health given the historical link between GdP per capita 
and life expectancy across nations.12
the belief that the ttiP would produce a significant 
economic benefit for the eU as well as the UsA is in-
deed supported by a study commissioned by the euro-
pean commission (ec). the center for economic Poli-
cy research (cePr) estimated that the ttiP can increase 
the size of the eU economy by around€120 billion euros, 
about 0.5% of its Gross domestic Product (GdP) and 
the UsA by 95 euros billion (0.4% of GdP).6 Another 
study published by the Austrian Foundation for develop-
ment research (oFse), although characterizing the po-
tential economic benefits of the ttiP as “overly optimis-
tic”, confirmed these economic growth projections.13
such encouraging estimates have not been supported by 
an investigation by the Global development and envi-
ronment institute, however, which concluded that the 
ttiP would lead to a contraction, instead of an increase 
in GdP.14 there are also several important limitations for 
the use of GdP as a measure of both progress and nation-
al welfare,15 given its diminishing returns in promoting 
longer life expectancy in wealthy nations16 and its impact 
on the environment.17,18 Moreover, the impact of trade 
policies on population health, especially in wealthy na-
tions, largely depends on their distributional effects: in-
come-generating reforms can lead to better health to the 
extent that such income “trickles down” to the lower soci-
oeconomic strata of the population leading to a reduction 
of income inequality.19,20
trade liberalization policies, however, have been associ-
ated with widening economic inequalities, rather than 
vice versa. Although proponents of the ttiP claim that 
the treaty will produce benefits not only to economic 
growth, but also to employment and productivity,21 in re-
ality trade liberalization policies have so far shown to cre-
ate a few “winners”, such as large tncs, which account 
for about two thirds of trade worldwide, and far too many 
“losers” especially in low-skilled occupations.22-24 evi-
dence from the north American Free trade Agreement 
(nAFtA), that facilitated the penetration of tncs into 
foreign markets, but reduced employment and wage levels 
in the UsA especially in the manufacturing sector,25 cor-
roborates the hypothesis that trade liberalization tend to 
produce regressive distributional effects.
THE TTIP AND DETERMINANTS Of HEALTH
in order to analyse more specifically the health effects of 
the ttiP, we decided to examine the following categories 
of risk factors or determinants of health:
n access to medicines and healthcare; 
n tobacco and alcohol consumption
n diet-related diseases and agriculture;
n environmental health.
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ACCESS TO MEDICINE 
AND HEALTHCARE
TOBACCO
AND ALCOHOL
CONSUMPTION
DIET-RELATED DISEASES
AND AGRICULTURE
ENVIRONMENTAL 
HEALTH
TECHNICAL BARRIERS
TO TRADE (TBT)
Research cooperation
and reduced duplication 
of processes
Imports of alcohol 
products
Imports of tobacco 
products
Alcohol and tobacco  
consumption
INTELLECTUAL PROPERTy 
(IP)
AND TRADE-RELATED
ASPECTS Of INTELLECTUAL 
PROPERTy RIGHTS
(TRIPS)
Price 
of prescription drugs
Access 
to prescription drugs
TRADE IN SERVICES
(TIS)
Privatization 
of healthcare services
Access to healthcare 
services
INVESTOR TO STATE
DISPUTE SETTLEMENT 
(ISDS)
Tobacco advertising 
restrictions
Tobacco smoking 
prevalence
Alcohol advertising 
restrictions
Alcohol consumption
Regulations 
and labelling systems 
of food products
Consumption 
of ultra-processed 
products
Prevalence 
of obesity, diabetes 
and diet-related 
chronic diseases
Regulations on 
extraction, transporta-
tion 
and exportation 
of fossil fuels
Diseases of the lungs, 
liver, kidneys, blood 
and brain
Greenhouse gas 
emissions
Climate-change 
related mortality 
and morbidity
SANITARy
AND PHyTOSANITARy 
STANDARDS
(SPS)
Regulations 
on additives, 
contaminants, toxins 
or disease-causing 
organisms in food, 
beverages, feedstuffs, 
plant and animal-carried 
diseases
Prevalence of food-born 
diseases
Table 1. TTIP provisions and determinants of health.
Tabella 1. TTIP: disposizioni e determinanti della salute. 
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ACCESS TO MEDICINES AND HEALTHCARE
the ttiP is likely to affect both access to medicines and 
access to healthcare. By reducing technical Barriers to 
trade (tBt) and by promoting increased cooperation be-
tween institutions such as the european Medicines Agen-
cy (eMA) and the Food and drug Administration (FdA), 
the ttiP could result in improved research cooperation 
and reduced duplication of processes.10,16 However, the 
treaty also contains a chapter on intellectual Property (iP) 
and trade-related Aspects of intellectual Property rights 
(triPs) that include changes in intellectual property reg-
ulations and limits on pricing and reimbursement policies. 
Both categories of provisions may result in an expansion 
and extension of patent monopolies, increased prices for 
pharmaceuticals, and delayed availability of generic drugs. 
increasing the cost for prescription pharmaceuticals is like-
ly to increase not only financial strain, but also cause under-
utilization of needed medications among vulnerable pop-
ulations such as low-income people, women, minorities, 
the elderly and people with (multiple) chronic diseases.26 it 
may also result in higher cost for medications at the nation-
al level: the lack of provision of government intervention in 
negotiating drug price in Medicare in the Us, for example, 
cost between 15.2 and 16 billion annually.27
Another very important chapter of the ttiP is the trade 
in services (tis) chapter, which includes clauses requiring 
publicly run health services to be opened up to competi-
tion from private sector healthcare providers. existing lit-
erature clearly shows that privatization of health services 
leads to inequities in access to healthcare and a reduction 
of utilization of needed care especially among vulnera-
ble populations.7 lack of health coverage is also a deter-
minant of higher mortality and morbidities among the 
population.28 the tis also includes the so-called “ratch-
et clause” that would preclude the possibility of privatized 
public services being returned to state operation, which 
is a serious infringement against the liberty of nations 
to make decisions about their own healthcare system of 
choice. Finally, since both access to medicines and access 
to healthcare are matter of life and death for millions of 
individuals, it is plausible to argue that the ttiP infring-
es “the right to live.”
TObACCO AND ALCOHOL CONSUMPTION
Another serious potential effect of the 
ttiP could be to undermine nation-
al laws that regulate and restrict the 
consumption of cigarettes and al-
cohol, which are responsible for an 
important proportion of prema-
ture deaths in both the eU and the 
UsA9,29 and a list of largely preventable morbidities in-
cluding lung cancer and cardiovascular diseases.30,31 no 
study so far has estimated the potential increase in ciga-
rettes smoking and alcohol consumption resulting from 
the ttiP. However, there is clear evidence that the treaty 
can limit the development and implementation of policies 
aimed at curbing both epidemics.
the ttiP contains the proposed inclusion of the inves-
tor to state dispute settlement (isds) arbitration system. 
the isds is a mechanism that allows foreign investors to 
sue states hosting their investment before international pri-
vate arbitration courts any time a government policy or law 
reduces the value of their investment. transnational tobac-
co companies have proven to be very keen on using the 
isds. Philip Morris international sued Uruguay in 2010 
for placing large health warnings on tobacco products, ar-
guing that the government violated the investment protec-
tion agreement signed in 1991 between Uruguay and swit-
zerland (where Philip Morris is headquartered).32,33 Philip 
Morris international has also sued Australia for plain pack-
aging of tobacco products – the removal of colours, log-
os and other marketing materials from tobacco contain-
ers and the placement of enlarged graphic health warnings. 
this is very serious because evidence showed that package 
design affects perceptions about the desirability of smok-
ing,34-36 and health warnings on tobacco containers have 
been shown to increase awareness of the health effects of 
smoking and encourage smoking cessation.37,38
Provisions proposed for the ttiP may also have an im-
pact on measures to reduce excessive alcohol consump-
tion. reduced tariffs and increased imports of alcohol 
products resulting from the ttiP are expected to increase 
alcohol-related diseases,16 especially if concomitant [poli-
cies on] restrictions on alcohol availability, bans or limits 
on alcohol advertising and pregnancy warning labels are 
challenged on the ground that they are barriers to trade 
through the tBt provision. Based on evidence on the 
relationship between cost of alcohol and consumption, 
scotland sought to introduce a minimum price of 0.53 
euros per unit of alcohol. the law, however, faced sub-
stantial resistance from the alcohol industry, the europe-
an commission and other european countries on 
the ground that it could generate a negative 
impact on trade.10
DIET-RELATED DISEASES 
AND AGRICULTURE
the ttiP is also designed to harmo-
nize norms and standards on trade 
and weaken regulatory regimes that 
can affect dietary patterns and food 
Private arbitration 
system can infringe 
against the liberty 
of nations 
98
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safety. deregulation, however, is a 
potential risk factor for obesity and 
overweight: a cross-national lon-
gitudinal study among wealthy na-
tions found that governments pursu-
ing more aggressive policies of market 
deregulation experienced faster increas-
es in consumption of unhealthy ultra-pro-
cessed products such as fast food and soft drinks 
as well as faster increases in obesity.39 numerous studies 
have also shown that policies of trade liberalization are as-
sociated with a nutrition transition toward unhealthy ul-
tra-processed products40-42 that are risk factors for obesi-
ty and diabetes. A revealing example is nAFtA passed in 
1994 that resulted in a significant reduction of tariffs on 
sugar-sweetened beverages and other unhealthy food prod-
ucts40 and the penetration of transnational soft drink and 
fast food companies in Mexico. Between 1996 and 2006, 
the consumption of high-energy beverages in Mexico more 
than doubled among adolescents and tripled among adult 
women.43 Mexico has now the second highest prevalence 
of soft drinks consumption44 and one of the highest preva-
lence of diabetes in the world.45
With regard to the potential of the ttiP to affect future 
and current regulations designed to promote a healthy 
diet, countries and tncs have invoked the tBt pro-
vision to oppose certain food policies. in 2006, thai-
land proposed the introduction of a front-of-pack “traf-
fic light” labelling system on snack food products. the 
Us and other countries, however, claimed that such pol-
icy violated the tBt agreement causing the thai gov-
ernment to abandon the proposed traffic light system.10 
Another important case in point is chile’s new law “nu-
tritional composition of nutrients and their Advertis-
ing,” the first regulation in the world to require label-
warning statements on food products high in fat, sugar 
and salt.5,46during a meeting discussing tBt, representa-
tives of the eU and the Us claimed that the requirements 
of the chilean law were not based on relevant codex nu-
trition labelling guidelines and that they would create un-
necessary barriers to trade.10
if the tBt can affect food regulations, the ttiP provision 
called sanitary and Phytosanitary Measures (sPs) can in-
fluence standards on risks arising from additives, contam-
inants, toxins or disease-causing organisms in food, bev-
erages, feedstuffs, and plant and animal-carried diseases. 
the sPs provision, together with regulatory convergence, 
can weaken regulations on food and agriculture, with po-
tentially serious consequences for food safety. the centers 
for disease control and Prevention (cdc) estimated that 
each year, in the Us, about 48 million people become sick 
and 3,000 die of foodborne diseas-
es.47 the eU had 48,964 cases and 
46 deaths in 2009, the most recent 
year examined.48 Although inter-
national comparisons on mortality 
and morbidity due to foodborne dis-
eases are difficult to make due to heter-
ogeneity in data collection, under-reporting 
and standardization, it is generally well known 
that eU policies on food safety are far more stringent than 
those applied in the Us. Finally, the ttiP is likely to lead 
to increased imports of hormone treated beef, chlorine 
treated chickens, and Genetically Modified (GM) crops 
that are illegal or subject to restrictions within the eU, but 
allowed in the Us.10
ENVIRONMENTAL HEALTH
Arguably, the most serious health effect of the ttiP re-
gards its capability to affect environmental policies. cli-
mate change is widely considered the most important 
global health threat of the century and can even result 
in the collapse of modern civilization.49,50 Health conse-
quences of climate change include heat-related illnesses 
and deaths, extreme weather-related health effects, air pol-
lution-related health effects, allergic diseases, water- and 
food-borne diseases, vector- and rodent-borne diseases, 
malnutrition, storm surge-related drowning and injuries 
and health problems of displaced populations. it can also 
produce indirect health effects due to violence and con-
flicts resulting from climate-change related declines in ba-
sic resources.51climate scientists proposed that the aim of 
humanity should be to stop average global temperatures 
from rising to more than 2ºc above the pre-industrial lev-
el to avoid exceeding the so-called “point of no return” of 
irreversible climate change.52 However, in order to reach 
this goal, researchers estimated that about three quarters 
of coal, oil and gas have to be considered “un-burnable 
carbon” and should be left in the ground.53 this dramat-
ic reduction in the use of fossil fuels, however, seems vir-
tually unthinkable without a radical transformation of the 
global economy and stronger regulations limiting green-
house gas emissions by industries and consumers. the 
ttiP, as argued in a 2013 paper by the centre for inter-
national environmental law, can actually restrain the de-
velopment of stronger environmental laws,54 and encour-
age the extraction and export of fossil fuels such oil and 
gas. this is in line with previous FtAs and policies of the 
World trade organization (Wto) that have consistent-
ly opposed the development of stronger measures for the 
protection of the environment and health.9 during the 
negotiations of the Paris United nations climate confer-
Hormone-treated beef 
and chlorinated chickens: 
TTIP 
could increase
 their importation
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ence, or coP21, a leaked internal 
eU document revealed that euro-
pean governments have instructed 
their representatives to oppose any 
discussion of measures to combat cli-
mate change that might be a “restric-
tion on international trade”.55 clearly, 
free trade policies are incompatible with the 
global effort to avert climate catastrophe.
the isds provision is very likely to be exploited by large 
fossil fuel companies to sue governments that try to lim-
it extraction and export of these fossil fuels. A revealing 
precedent is the case of the canadian government sued 
by a Us-based mining company called lone Pine for its 
ban on “hydraulic fracturing” in Quebec after the passage 
of nAFtA. “Fracking”, a process in which energy com-
panies inject a mixture of water, sand and chemicals into 
the ground in order to blast apart shale formations and 
extract natural gas, does not only contributes to the cli-
mate change crisis, but can also produce adverse health 
consequences especially among households near produc-
tion sites. in spite of the paucity of studies on the top-
ic, a recent literature review showed that possible health 
effects produced by hydraulic fracturing of shale include 
congenital birth defects, cancer and cardiovascular diseas-
es.56 Another case involving the isds provision of nAF-
tA regards the launch of a 15 billion dollars lawsuit by 
transcanada corp. against the Us government for reject-
ing Keystone Xl – an oil pipeline running from Alberta 
(canada) to texas (UsA) – because of its potential impact 
on efforts to combat climate change.
POLICy IMPLICATIONS
Proponents of the ttiP claim that this trade treaty has 
the potential to promote health-enhancing determinants 
such as economic growth and employment and may gen-
erate positive effects in terms of population health. oppo-
nents of the agreement argue exactly the opposite. our re-
view suggests that although some studies have supported 
the hypothesis that the ttiP will have a positive impact 
on economic and employment indicators, these chang-
es may not necessarily “trickle down” to the lowest so-
cioeconomic strata of the population. on the contrary, 
trade liberalization policies tend to produce regressive dis-
tributional effects. tariff reduction, for example, can re-
duce the tax-raising capability of governments to invest in 
health, social welfare and education, with obvious reper-
cussions on economic inequality and public health out-
comes. Another potential danger of the ttiP regards the 
use of isds by tncs to challenge policies that reduce 
economic inequality. A case in point regards the legal ac-
tion by Veolia group – a French 
tnc – that sued the egyptian 
government for raising the mini-
mum monthly wage.22,57
Further evidence and impact assess-
ments are needed to further inform ne-
gotiators on the likely impact of the ttiP 
on health outcomes. However, available evi-
dence presented in this article provides a caution-
ary tale on the potential influence of this treaty on determi-
nants of health such as access to medicines and healthcare, 
tobacco and alcohol consumption, diet-related diseases and 
agriculture and environmental health. By reducing tech-
nical Barriers to trade (tBt) and by promoting increased 
cooperation between Us and eU governmental agencies 
in the pharmaceutical sector, the ttiP may result in im-
proved research cooperation and reduced duplication of 
processes. However, the ttiP chapters on intellectual 
Property (iP) and on trade-related Aspects of intellectu-
al Property rights (triPs) that expand and extend pat-
ent monopolies, and delay the availability of generic drugs, 
are likely to cause underutilization of needed medications 
among vulnerable populations. the tis chapter, that in-
cludes the so-called “ratchet clause” would preclude the 
possibility of privatized public services being returned to 
state operation, and would thus be likely to reduce access 
to universal healthcare among the most vulnerable sectors 
of the population.
the ttiP’s isds private arbitration system is likely to 
produce a negative impact on regulations aimed at increas-
ing access to medicines and healthcare, and policies that 
reduce tobacco use, alcohol consumption and diet-related 
diseases. the sanitary and Phytosanitary standards (sPs) 
chapter of the ttiP is expected to weaken regulations in 
the food and agricultural sectors especially in the eU, with 
potentially negative effects on food safety and food-borne 
diseases. Finally, the isds is likely to impair the ability of 
governments to tackle environmental problems such as cli-
mate change, deemed to become the most important glob-
al health threat of the century.
Proponents and critics of the ttiP tend, in general, to use 
different approaches in assessing the evidence on its poten-
tial effects. Proponents are generally in favour of an approach 
to regulation that allows for a ban or restrictions to a given 
product or service only after full evidence that such prod-
uct or service is harmful to health is provided and total cer-
tainty is achieved. the Wto, tncs and the UsA support 
this approach. in 1998, for example, canada and the Us 
imposed sanctions amounting to 150 million dollars on the 
eU in retaliation for a ban on hormone-treated beef imports 
by the eU2,58 on the grounds that there was insufficient ev-
TTIP 
poses a treat
to universal access
to healthcare
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idence to support the ban. some have called this “evidence-
based approach” in contrast to the “precautionary principle 
approach” that states that lack of full scientific certainty does 
not justify postponement of measures that can protect pop-
ulation health and the environment.16,59 in reality, the “pre-
cautionary principle approach” relies on evidence as much 
as the so-called “evidence-based approach”, with the differ-
ence that it shifts to proponents of new products or policies 
the responsibility for demonstrating the safety of such prod-
ucts and policies based on scientific evidence. Accordingly, it 
is up to the proponents of the ttiP to demonstrate empiri-
cally, before the partnership is approved, that the treaty is not 
harmful to population health and the environment.
Proponents of the ttiP claim that the treaty will pro-
mote the exchange of needed goods and services between 
countries without causing a “race to the bottom” impair-
ing regulations to protect public health and the environ-
ment. in reality, however, historical evidence already 
exists and shows that FtAs can discour-
age regulations on access to medicines 
and healthcare, tobacco and alcohol 
consumption, diet-related diseases 
and agriculture and environmen-
tal health. Moreover, the ability 
of tncs to raise legal challeng-
es against states that adopt pub-
lic health regulations under the 
isds as well as the irreversibility 
of privatization of healthcare servic-
es limit “health policy space” or the 
freedom of governments to chose, de-
sign and implement healthy public poli-
cies. Furthermore, as susan George has not-
ed, there is no reciprocity on the ttiP: tncs can 
sue governments, but not the other way round, nor can 
the private arbitration tribunal’s decision be appealed.60 
this has serious implications for democracy. there is al-
ready evidence that FtAs such as the ttiP can promote 
so-called “regulatory chill” – any impact that market forc-
es can produce on public policy regulators when they per-
suade them to refrain from developing, introducing and 
revising regulations aimed at protecting health and the 
environment.10 the threat of litigation has already pro-
duced an impact in new zealand where the government 
explicitly announced that it had postponed plain packag-
ing legislation until the Philip Morris vs. Australia case 
was resolved.5 Another case in point concerns the cana-
dian Government that stepped back from the initial com-
mitment to introduce plain packaging in 1994 because of 
threatened action under the isds of nAFtA.61
When considering the “ratchet clause” that locks in cur-
rent or future privatization of healthcare services, the 
dutch firm Achmea sued the slovak republic over the 
impending expropriation of private health insurance com-
panies linked to the slovak’s government’s plan to devel-
op a single state-operated health insurance company.10,22 
this is clearly another blatant example of how the ttiP 
can infringe the ability of governments to determine their 
own policies and undermine national sovereignty.
overall, the ttiP may not only affect public health outcomes 
negatively and undermine democracy, but also produce a fur-
ther imbalance of power between large private companies and 
the public. it is important to stress that the top ttiP lob-
bying groups represent corporations and about 92% 
of consultation meetings for the ttiP prior to 
the opening of the negotiations were carried 
out with these private companies or their 
representatives.62 there has been little 
or no involvement of civic society or-
ganizations and public health profes-
sionals in spite of the likely effects of 
the ttiP on social and health out-
comes. Moreover, negotiations have 
been long kept in secret and they 
have become public only after the or-
ganized efforts of civic society.63
Most critics of the ttiP harbor no ide-
ological preclusion against healthy free 
trade agreements, cooperation or harmoniza-
tion of policies and regulations between the eU and 
the UsA. However, trade policy should not treat regula-
tions designed to protect public health as technical barriers 
to trade, and the “right to profit” should not be prioritized 
over “the right to health”.60 Harmonization of regulations, 
norms and standards may indeed be desirable, but in the 
direction of a stronger protection of the environment and 
population health.
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